Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
305.84B
Market cap305.84B
Price-Earnings ratio
33.99
Price-Earnings ratio33.99
Dividend yield
2.78%
Dividend yield2.78%
Average volume
8.85M
Average volume8.85M
High today
$125.02
High today$125.02
Low today
$122.58
Low today$122.58
Open price
$124.16
Open price$124.16
Volume
3.68M
Volume3.68M
52 Week high
$130.29
52 Week high$130.29
52 Week low
$76.66
52 Week low$76.66

Stock Snapshot

As of today, Merck(MRK) shares are valued at $123.83. The company's market cap stands at 305.84B, with a P/E ratio of 33.99 and a dividend yield of 2.78%.

On 2026-07-15, Merck(MRK) stock traded between a low of $122.58 and a high of $125.02. Shares are currently priced at $123.83, which is +1.0% above the low and -1.0% below the high.

Merck(MRK) shares are trading with a volume of 3.68M, against a daily average of 8.85M.

During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $130.29 at its peak.

During the past year, Merck(MRK) stock moved between $76.66 at its lowest and $130.29 at its peak.

MRK News

Investing.com 4h
Why is Merck stock rallying today? - Investing.com

...

Why is Merck stock rallying today? - Investing.com
Seeking Alpha 5h
Merck posts late-stage trial win for frontline Keytruda in endometrial cancer

Merck (MRK) on Wednesday announced that its anti-PD-1 therapy, Keytruda, when used as a frontline monotherapy for certain patients with endometrial cancer, met...

Merck posts late-stage trial win for frontline Keytruda in endometrial cancer
TipRanks 6h
Merck to present new data from research pipeline for HIV treatment, prevention

Merck (MRK) announced that new data from its research pipeline for HIV treatment and prevention will be presented at the 26th International AIDS Conference, AID...

Analyst ratings

66%

of 29 ratings
Buy
65.5%
Hold
27.6%
Sell
6.9%

More MRK News

TipRanks 6h
Merck says Phase 3 KEYNOTE-C93 trial of Keytruda met primary endpoint

Merck (MRK) announced the Phase 3 KEYNOTE-C93 trial evaluating Keytruda, Merck’s anti-PD-1 therapy, met its primary endpoint of progression-free survival for th...

Benzinga 2d
Why Merck Stock Is in the Spotlight Today

Merck & Co. Inc. (NYSE:MRK) shares are in focus Monday after a wave of analyst activity capped by a new FDA approval for its cancer drug Keytruda. Merck stock i...

Why Merck Stock Is in the Spotlight Today
Simply Wall St 4d
Can Merck Be A Bargain If Earnings Look Fair?

Merck stock has delivered an 85.1% total return over the past five years, yet the current checks send a mixed message, with a Discounted Cash Flow (DCF) intrins...

Can Merck Be A Bargain If Earnings Look Fair?
Nasdaq 5d
Merck Stock Sinks As Market Gains: Here's Why

Merck (MRK) closed the latest trading day at $113.09, indicating a -1.43% change from the previous session's end. This change lagged the S&P 500's daily gain of...

Merck Stock Sinks As Market Gains: Here's Why
TipRanks 5d
Merck confirms FDA approves Keytruda combos with Padcev

Merck (MRK) announced the U.S. Food and Drug Administration approved KEYTRUDA and KEYTRUDA QLEX, Merck’s anti-PD-1 therapies, each in combination with Padcev, a...

Nasdaq 6d
Merck & Co., Inc. is Attracting Investor Attention: Here is What You Should Know

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influenc...

Merck & Co., Inc. is Attracting Investor Attention: Here is What You Should Know

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.